s6y

Vicore Pharma Holding AB

Ticker
VCRE
CIK
2124403
Industry
Pharmaceutical Preparations

Prospectus 2

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Other 11

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. SCHEDULE 13G
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. SEC STAFF ACTION
  9. CERT Certification by an exchange approving securities for listing
  10. 20FR12B/A Form for initial registration of a class of securities of foreign private issuers pursuant to Section 12(b)

All 11 other filings